These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 32990819

  • 1. [18F]MPPF and [18F]FDG μPET imaging in rats: impact of transport and restraint stress.
    Buchecker V, Waldron AM, van Dijk RM, Koska I, Brendel M, von Ungern-Sternberg B, Lindner S, Gildehaus FJ, Ziegler S, Bartenstein P, Potschka H.
    EJNMMI Res; 2020 Sep 29; 10(1):112. PubMed ID: 32990819
    [Abstract] [Full Text] [Related]

  • 2. Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model.
    Di Liberto V, van Dijk RM, Brendel M, Waldron AM, Möller C, Koska I, Seiffert I, Gualtieri F, Gildehaus FJ, von Ungern-Sternberg B, Lindner M, Ziegler S, Palme R, Hellweg R, Gass P, Bartenstein P, Potschka H.
    Neurobiol Dis; 2018 Oct 29; 118():9-21. PubMed ID: 29933054
    [Abstract] [Full Text] [Related]

  • 3. PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis.
    Bascuñana P, García-García L, Javela J, Fernández de la Rosa R, Shiha AA, Kelly J, Delgado M, Pozo MÁ.
    Neuroscience; 2019 Jun 15; 409():101-110. PubMed ID: 31034972
    [Abstract] [Full Text] [Related]

  • 4. Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model.
    van Dijk RM, Di Liberto V, Brendel M, Waldron AM, Möller C, Gildehaus FJ, von Ungern-Sternberg B, Lindner M, Ziegler S, Hellweg R, Gass P, Bartenstein P, Potschka H.
    Epilepsia; 2018 Dec 15; 59(12):2194-2205. PubMed ID: 30370531
    [Abstract] [Full Text] [Related]

  • 5. In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.
    Passchier J, van Waarde A, Pieterman RM, Elsinga PH, Pruim J, Hendrikse HN, Willemsen AT, Vaalburg W.
    J Nucl Med; 2000 Nov 15; 41(11):1830-5. PubMed ID: 11079490
    [Abstract] [Full Text] [Related]

  • 6. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
    la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, Cumming P.
    Neuroimage; 2010 Jan 15; 49(2):1406-15. PubMed ID: 19796699
    [Abstract] [Full Text] [Related]

  • 7. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.
    Zimmer L, Rbah L, Giacomelli F, Le Bars D, Renaud B.
    J Nucl Med; 2003 Sep 15; 44(9):1495-501. PubMed ID: 12960198
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of hippocampal neuronal loss and in vivo binding of 5-HT1a receptors in the KA model of limbic epilepsy in the rat.
    Van Bogaert P, De Tiège X, Vanderwinden JM, Damhaut P, Schiffmann SN, Goldman S.
    Epilepsy Res; 2001 Nov 15; 47(1-2):127-39. PubMed ID: 11673027
    [Abstract] [Full Text] [Related]

  • 9. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
    Vidal B, Sebti J, Verdurand M, Fieux S, Billard T, Streichenberger N, Troakes C, Newman-Tancredi A, Zimmer L.
    Neuropharmacology; 2016 Oct 15; 109():88-95. PubMed ID: 27183968
    [Abstract] [Full Text] [Related]

  • 10. Preclinical investigation of the effect of stress on the binding of [18F]F13640, a 5-HT1A radiopharmaceutical.
    Courault P, Bouvard S, Bouillot C, Zimmer L, Lancelot S.
    Nucl Med Biol; 2024 Jul 23; 138-139():108942. PubMed ID: 39151306
    [Abstract] [Full Text] [Related]

  • 11. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C, Lemaire C, Luxen A, Plenevaux A.
    Nucl Med Biol; 2006 Jul 23; 33(5):667-75. PubMed ID: 16843842
    [Abstract] [Full Text] [Related]

  • 12. Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: a pilot [(18)F]MPPF/PET study.
    Galusca B, Sigaud T, Costes N, Redoute J, Massoubre C, Estour B.
    World J Biol Psychiatry; 2014 Dec 23; 15(8):599-608. PubMed ID: 25054914
    [Abstract] [Full Text] [Related]

  • 13. Hippocampal 5-HT1A receptor binding is related to object-location memory in humans.
    Glikmann-Johnston Y, Saling MM, Chen J, O'Keefe G, Gong S, Tochon-Danguy H, Mulligan R, Reutens DC.
    Brain Struct Funct; 2015 Jan 23; 220(1):559-70. PubMed ID: 24807817
    [Abstract] [Full Text] [Related]

  • 14. Quantifying drug-related 5-HT1A receptor occupancy with.
    Passchier J, van Waarde A, Pieterman RM, Willemsen AT, Vaalburg W.
    Psychopharmacology (Berl); 2001 May 23; 155(2):193-7. PubMed ID: 11401009
    [Abstract] [Full Text] [Related]

  • 15. PIXSIC, a pixelated β⁺-sensitive probe for radiopharmacological investigations in rat brain: binding studies with [¹⁸F]MPPF.
    Balasse L, Maerk J, Pain F, Genoux A, Fieux S, Morel C, Gisquet-Verrier P, Zimmer L, Lanièce P.
    Mol Imaging Biol; 2015 Apr 23; 17(2):163-7. PubMed ID: 25138238
    [Abstract] [Full Text] [Related]

  • 16. Hippocampal and Septal 5-HT1A Receptor Expression in Two Rat Models of Temporal Lobe Epilepsy.
    Schönhoff K, von Rüden EL, Koska I, Seiffert I, Potschka H.
    Neuroscience; 2021 Jun 15; 465():219-230. PubMed ID: 33836244
    [Abstract] [Full Text] [Related]

  • 17. 18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging.
    Vidal B, Fieux S, Colom M, Billard T, Bouillot C, Barret O, Constantinescu C, Tamagnan G, Newman-Tancredi A, Zimmer L.
    Brain Struct Funct; 2018 Jul 15; 223(6):2973-2988. PubMed ID: 29730825
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
    Truchot L, Costes SN, Zimmer L, Laurent B, Le Bars D, Thomas-Antérion C, Croisile B, Mercier B, Hermier M, Vighetto A, Krolak-Salmon P.
    Neurology; 2007 Sep 04; 69(10):1012-7. PubMed ID: 17785670
    [Abstract] [Full Text] [Related]

  • 19. A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease.
    Truchot L, Costes N, Zimmer L, Laurent B, Le Bars D, Thomas-Antérion C, Mercier B, Hermier M, Vighetto A, Krolak-Salmon P.
    Neuroimage; 2008 Apr 15; 40(3):1251-6. PubMed ID: 18313943
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.